As of 2025-03-19, the Relative Valuation of Nuvo Pharmaceuticals Inc (MRV.TO) is 11.41 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.35 CAD, the upside of Nuvo Pharmaceuticals Inc based on Relative Valuation is 745.2%.
The range of the Relative Valuation is 7.56 - 16.18 CAD.
| Range | Selected | |
| Trailing P/E multiples | 5.7x - 8.0x | 6.8x |
| Forward P/E multiples | 8.4x - 12.2x | 10.3x |
| Fair Price | 7.56 - 16.18 | 11.41 |
| Upside | 459.8% - 1098.5% | 745.2% |
| Date | P/E |